GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DNA Print Genomics Inc (GREY:DNAG) » Definitions » Debt-to-Asset

DNA Print Genomics (DNA Print Genomics) Debt-to-Asset : 1.71 (As of Sep. 2007)


View and export this data going back to . Start your Free Trial

What is DNA Print Genomics Debt-to-Asset?

DNA Print Genomics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2007 was $5.07 Mil. DNA Print Genomics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2007 was $0.26 Mil. DNA Print Genomics's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2007 was $3.11 Mil. DNA Print Genomics's debt to asset for the quarter that ended in Sep. 2007 was 1.71.


DNA Print Genomics Debt-to-Asset Historical Data

The historical data trend for DNA Print Genomics's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DNA Print Genomics Debt-to-Asset Chart

DNA Print Genomics Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06
Debt-to-Asset
Get a 7-Day Free Trial 2.05 0.65 0.35 0.17 0.71

DNA Print Genomics Quarterly Data
Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.54 0.71 0.91 1.15 1.71

Competitive Comparison of DNA Print Genomics's Debt-to-Asset

For the Biotechnology subindustry, DNA Print Genomics's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DNA Print Genomics's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DNA Print Genomics's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where DNA Print Genomics's Debt-to-Asset falls into.



DNA Print Genomics Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

DNA Print Genomics's Debt-to-Asset for the fiscal year that ended in Dec. 2006 is calculated as

DNA Print Genomics's Debt-to-Asset for the quarter that ended in Sep. 2007 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DNA Print Genomics  (GREY:DNAG) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


DNA Print Genomics Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of DNA Print Genomics's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


DNA Print Genomics (DNA Print Genomics) Business Description

Traded in Other Exchanges
N/A
Address
1621 West University Parkway, Sarasota, FL, USA, 34243
DNA Print Genomics Inc is a pharmaceutical company that focuses on the human genome sciences. Through its subsidiaries, it is into research and development of genomic products and provides scientific services and tests to the genealogy, forensic, pharmaceutical, and genetics markets; and focuses on personalized medicine; and other operations.

DNA Print Genomics (DNA Print Genomics) Headlines

No Headlines